Literature DB >> 33641

Complement activation by Propionibacterium acnes and Bacteroides melaninogenicus.

K Okuda, K Yanagi, I Takazoe.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 33641     DOI: 10.1016/0003-9969(78)90296-0

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


× No keyword cloud information.
  6 in total

Review 1.  Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Authors:  Jennifer L Krauss; Jan Potempa; John D Lambris; George Hajishengallis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

2.  Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.

Authors:  C G Gemmell; P K Peterson; D Schmeling; J Mathews; P G Quie
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

3.  Characterization of opsonins for Bacteroides fragilis in immune sera collected from experimentally infected mice.

Authors:  T M Ellis; J T Barrett
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

4.  Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.

Authors:  G F Webster; U R Nilsson; W P McArthur
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

Review 5.  Pathogenic synergy: mixed intra-abdominal infections.

Authors:  D M MacLaren; F Namavar; A M Verweij-Van Vught; W A Vel; J A Kaan
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

6.  Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3.

Authors:  Michal Potempa; Jan Potempa; Tomasz Kantyka; Ky-Anh Nguyen; Katarzyna Wawrzonek; Surya P Manandhar; Katarzyna Popadiak; Kristian Riesbeck; Sigrun Eick; Anna M Blom
Journal:  PLoS Pathog       Date:  2009-02-27       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.